PIN Pharma Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $6.75M
Latest Deal Amount
  • Investors
  • 2

PIN Pharma General Information

Description

Developer of precision immune stimulants intended to link the innate and adaptive immune systems. The company's precision immune stimulants target breast and colon cancer to overcome cancer-mediated immune suppression, enabling physicians to perform treatment in an enhanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 55 Broadway
  • Suite 315
  • New York, NY 10032
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PIN Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Jan-2012 $6.75M 00.000 000.00 Completed Generating Revenue
To view PIN Pharma’s complete valuation and funding history, request access »

PIN Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 00 000
To view PIN Pharma’s complete cap table history, request access »

PIN Pharma Executive Team (3)

Name Title Board Seat Contact Info
Colin Bier Ph.D Chief Executive Officer, Chief Scientific Officer & President
Mark Smith Corporate Secretary, Chief Business Officer, Chief Finance Officer & Business Development Executive
Kenneth Gorelick MD Chief Medical Officer
To view PIN Pharma’s complete executive team members history, request access »

PIN Pharma Board Members (2)

Name Representing Role Since
Ivica Cerina Ph.D NGN Capital Board Member 000 0000
William Gedale JD NGN Capital Chairman 000 0000
To view PIN Pharma’s complete board members history, request access »

PIN Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NGN Capital Venture Capital Minority 000 0000 000000 0
Partnership for New York City Venture Capital Minority 000 0000 000000 0
To view PIN Pharma’s complete investors history, request access »